CAR-T cell developer bluebird bio Inc. has extended its potential US$1bn deal with cancer neoantigen TCR...
Up To Date
Latest News
British drug maker AstraZeneca’s IL-5Ralpha blocker benralizumab did not reduce exacerbations significantly...
A research team headed by Jean-Christophe Leroux from ETH Zurüch has created the first-ever 3-D printed mouth...
Following weeks of negotiations and four rejected bids, British neurology and orphan drug giant Shire has...
Vas Narasimhan, the newly appointed CEO of Swiss pharma giant Novartis, introduced himself to the Swiss...
Swiss injection pen developer Haselmeier and Boston-based Common Sensing have partnered to develop smart...